Contact us

Ivantis Completes $46.5 MM Financing;Receives Approval to Expand US Trial for Novel Glaucoma Device

Ivantis Completes a $46.5 MM Financing; Company Receives Approval to Expand US Pivotal Trial for Novel Glaucoma Device

Join our community!

Subscribe to our quarterly e-Newsletter, The Upside to find out what’s shaping the future industries of Singapore and the region.

Subscribe now
  • en
  • cn

    • English

    • English
    • Chinese

    © 2021- edbi. All rights reserved.